Document Detail

Early administration of thrombolysis can prevent myocardial necrosis: time is myocardium.
MedLine Citation:
PMID:  19546284     Owner:  NLM     Status:  MEDLINE    
A case is presented in which a 66-year-old man received thrombolysis for an acute ST elevation myocardial infarction (STEMI) within 6 minutes of developing chest pain. An ECG performed 10 minutes after thrombolysis showed complete resolution of the ST segment elevation and showed no other abnormality. An echocardiogram showed normal left ventricular function and there was no detectable myocardial necrosis, as evidenced by two negative troponin assays. The case clearly reinforces the benefits of the rapid delivery of thrombolysis when appropriate for patients with STEMI. Clinicians need to be aware of the benefits of early thrombolysis as laid out in the national service framework. Evidence for the early administration of thrombolysis, data from the Myocardial Infarction National Audit Project and the future with regard to improving thrombolysis times are discussed.
A Suri; S Ahsan; J Lim; T-P Cusack; T P Chua; E W Leatham
Related Documents :
12604874 - Significance of thrombolysis in myocardial infarction (timi) grade 2 flow early after t...
8409074 - Identification of a secondary peak in myocardial infarction onset 11 to 12 hours after ...
14996574 - Association of peripheral neutrophilia with adverse angiographic outcomes in st-elevati...
6578454 - Coronary care at hutt hospital 1980-1981.
18609044 - No touch vein harvesting technique for cabg improves the long-term clinical outcome.
2005454 - Comparison of myocardial imaging with iodine-123-iodophenyl-9-methyl pentadecanoic acid...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Emergency medicine journal : EMJ     Volume:  26     ISSN:  1472-0213     ISO Abbreviation:  Emerg Med J     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-06-23     Completed Date:  2009-11-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100963089     Medline TA:  Emerg Med J     Country:  England    
Other Details:
Languages:  eng     Pagination:  541-2     Citation Subset:  IM    
Department of Cardiology, Royal Surrey County Hospital, Guildford, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Fibrinolytic Agents / therapeutic use*
Myocardial Infarction / drug therapy*
Myocardium / pathology*
Necrosis / prevention & control
Tissue Plasminogen Activator / therapeutic use*
Reg. No./Substance:
0/Fibrinolytic Agents; 0/tenecteplase; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Importance of the log roll.
Next Document:  Calcific tendonitis of the medial collateral ligament.